Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Inventory Average (2018 - 2025)

Historic Inventory Average for Agios Pharmaceuticals (AGIO) over the last 7 years, with Q4 2025 value amounting to $32.5 million.

  • Agios Pharmaceuticals' Inventory Average rose 2018.5% to $32.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $32.5 million, marking a year-over-year increase of 2018.5%. This contributed to the annual value of $30.3 million for FY2025, which is 2964.96% up from last year.
  • Per Agios Pharmaceuticals' latest filing, its Inventory Average stood at $32.5 million for Q4 2025, which was up 2018.5% from $31.4 million recorded in Q3 2025.
  • In the past 5 years, Agios Pharmaceuticals' Inventory Average registered a high of $32.5 million during Q4 2025, and its lowest value of $3.3 million during Q2 2022.
  • Over the past 4 years, Agios Pharmaceuticals' median Inventory Average value was $21.1 million (recorded in 2024), while the average stood at $19.5 million.
  • Its Inventory Average has fluctuated over the past 5 years, first surged by 31321.62% in 2023, then soared by 2018.5% in 2025.
  • Quarter analysis of 4 years shows Agios Pharmaceuticals' Inventory Average stood at $6.8 million in 2022, then surged by 165.95% to $18.2 million in 2023, then surged by 48.68% to $27.0 million in 2024, then grew by 20.19% to $32.5 million in 2025.
  • Its last three reported values are $32.5 million in Q4 2025, $31.4 million for Q3 2025, and $30.2 million during Q2 2025.